Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 16
|
pp. 8204–8219
PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
Back to article
Figure 2
(2 of 6)
−
100%
+
Figure 2.
Enrichment analysis and PPI network construction.
(
A
) GO analysis. (
B
) KEGG analysis.
